What Happened?
Shares of diversified science and technology company Danaher (NYSE: DHR) jumped 6.6% in the afternoon session after the company reported impressive first quarter 2025 results, which beat analysts' organic revenue and EPS expectations. Revenue was flat year-over-year on a core basis, which masked a 7% gain in biotech and a modest decline in life sciences, revealing the uneven recovery across business lines. Looking ahead, sales guidance for the next quarter was ahead, while full year EPS guidance also beat Wall Street's expectations. Overall, we think this was a solid quarter with some key areas of upside.
After the initial pop the shares cooled down to $193.68, up 4.8% from previous close.
Is now the time to buy Danaher? Access our full analysis report here, it’s free.
What The Market Is Telling Us
Danaher’s shares are not very volatile and have only had 6 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
Danaher is down 15.7% since the beginning of the year, and at $193.68 per share, it is trading 31% below its 52-week high of $280.76 from July 2024. Investors who bought $1,000 worth of Danaher’s shares 5 years ago would now be looking at an investment worth $1,209.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
